{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T17:21:56Z","timestamp":1783358516434,"version":"3.54.6"},"reference-count":59,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Neisseria gonorrhoeae (NG) has developed antimicrobial resistance (AMR) to multiple classes of antibiotics. While treatment of symptomatic NG in groups, such as men who have sex with men (MSM), is crucial, screening programs targeting asymptomatic NG cases may contribute to excessive antibiotic exposure of the population and thus to the emergence of gonococcal AMR. Our primary aim was to assess if intense screening could promote AMR in NG.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We built a network-based model of NG transmission dynamics among MSM in Belgium to estimate the prevalence of NG in the population and the risk of AMR. The model simulates daily transmission of NG among 3 anatomical sites in a population of 10 000 MSM, grouped as low risk or high risk, over 10 years. The effect of group-wise variation in treatment efficacy levels and screening intensities on NG prevalence and cumulative risk of AMR emergence was evaluated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Increasing screening intensity in the low-risk MSM had little effect on NG prevalence. An inverse correlation between screening intensity in the high-risk group and both NG prevalence and the risk for azithromycin resistance was observed, irrespective of the screening intensity in the low-risk group. High-risk MSM were at higher risk for azithromycin-resistant NG in all screening intensity and treatment efficacy scenarios, compared to low-risk MSM.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our results suggest that intensive screening in the low-risk population has little impact on prevalence but may increase the probability of AMR emerging. In contrast, intensive screening in the high-risk population reduces both the prevalence of NG and macrolide resistance.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofad165","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T11:18:43Z","timestamp":1679915923000},"source":"Crossref","is-referenced-by-count":17,"title":["Rethinking Screening Intensity in Terms of Reducing Prevalence or Increasing Selection Pressure for the Emergence of Resistant Gonorrhea: A Modeling Study of Men Who Have Sex With Men in Belgium"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7565-1359","authenticated-orcid":false,"given":"Achilleas","family":"Tsoumanis","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences, Institute of Tropical Medicine Antwerp , Antwerp , Belgium"},{"name":"Centre for Health Economics Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp , Antwerp , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8010-1351","authenticated-orcid":false,"given":"Christophe","family":"Van Dijck","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Institute of Tropical Medicine Antwerp , Antwerp , Belgium"},{"name":"Laboratory of Medical Microbiology, University of Antwerp , Antwerp , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1881-0637","authenticated-orcid":false,"given":"Niel","family":"Hens","sequence":"additional","affiliation":[{"name":"Centre for Health Economics Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp , Antwerp , Belgium"},{"name":"Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Data Science Institute, Hasselt University , Hasselt , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Kenyon","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Institute of Tropical Medicine Antwerp , Antwerp , Belgium"},{"name":"Division of Infectious Diseases and HIV Medicine, Department of Medicine, University of Cape Town , Cape Town , South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,3,27]]},"reference":[{"key":"2023042714160618900_ofad165-B1","author":"European Centre for Disease Prevention and Control (ECDC)","year":"2020"},{"key":"2023042714160618900_ofad165-B2","author":"Centers for Disease Prevention and Control (CDC)","year":"2021"},{"key":"2023042714160618900_ofad165-B3","author":"World Health Organization (WHO)","year":"2011"},{"key":"2023042714160618900_ofad165-B4","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines","volume":"64(RR-03)","author":"Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"key":"2023042714160618900_ofad165-B5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-1293.2011.00971.x","article-title":"British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011","volume":"13","author":"Asboe","year":"2012","journal-title":"HIV Med"},{"key":"2023042714160618900_ofad165-B6","author":"Sexually Transmissible Infections in Gay Men Action Group","year":"2014"},{"key":"2023042714160618900_ofad165-B7","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1071\/SH15183","article-title":"Characteristics of gonorrhoea cases notified in inner and south-western Sydney, Australia: results of population-based enhanced surveillance","volume":"13","author":"Ingleton","year":"2016","journal-title":"Sex Health"},{"key":"2023042714160618900_ofad165-B8","author":"Public Health Agency of Canada","year":"2010"},{"key":"2023042714160618900_ofad165-B9","volume-title":"HIV and STI prevention among men who have sex with men","author":"European Centre for Disease Prevention and Control (ECDC)","year":"2015"},{"key":"2023042714160618900_ofad165-B10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001598","article-title":"Molecular diagnostics for gonorrhoea: implications for antimicrobial resistance and the threat of untreatable gonorrhoea","volume":"11","author":"Low","year":"2014","journal-title":"PLoS Med"},{"key":"2023042714160618900_ofad165-B11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6507a1","article-title":"Antimicrobial susceptibility surveillance\u2014the gonococcal isolate surveillance project, 27 sites, United States, 2014","volume":"65","author":"Kirkcaldy","year":"2016","journal-title":"MMWR Surveill Summ"},{"key":"2023042714160618900_ofad165-B12","author":"Centers for Disease Control and Prevention","year":"2016"},{"key":"2023042714160618900_ofad165-B13","author":"Jespers","year":"2019"},{"key":"2023042714160618900_ofad165-B14","author":"World Health Organization (WHO)","year":"2016"},{"key":"2023042714160618900_ofad165-B15","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1177\/09564624211025940","article-title":"Screening for STIs is one of the main drivers of macrolide consumption in PrEP users","volume":"32","author":"Vanbaelen","year":"2021","journal-title":"Int J STD AIDS"},{"key":"2023042714160618900_ofad165-B16","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1177\/0956462420957519","article-title":"Screening for STIs in PrEP cohorts results in high levels of antimicrobial consumption","volume":"31","author":"Kenyon","year":"2020","journal-title":"Int J STD AIDS"},{"key":"2023042714160618900_ofad165-B17","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1093\/infdis\/jiab178","article-title":"Dual azithromycin\/ceftriaxone therapy for gonorrhea in PrEP cohorts results in levels of macrolide consumption that exceed resistance thresholds by up to 7-fold","volume":"224","author":"Kenyon","year":"2021","journal-title":"J Infect Dis"},{"key":"2023042714160618900_ofad165-B18","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/OLQ.0000000000000824","article-title":"Is screening for chlamydia and gonorrhea in men who have sex with men associated with reduction of the prevalence of these infections? A systematic review of observational studies","volume":"45","author":"Tsoumanis","year":"2018","journal-title":"Sex Transm Dis"},{"key":"2023042714160618900_ofad165-B19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248582","article-title":"Changes in the prevalence of self-reported sexually transmitted bacterial infections from 2010 and 2017 in two large European samples of men having sex with men\u2014is it time to reevaluate STI-screening as a control strategy?","volume":"16","author":"Marcus","year":"2021","journal-title":"PLoS One"},{"key":"2023042714160618900_ofad165-B20","doi-asserted-by":"crossref","first-page":"160","DOI":"10.12688\/f1000research.17955.1","article-title":"Screening is not associated with reduced incidence of gonorrhoea or chlamydia in men who have sex with men (MSM); an ecological study of 23 European countries","volume":"8","author":"Kenyon","year":"2019","journal-title":"F1000Res"},{"key":"2023042714160618900_ofad165-B21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1017\/S0950268818000092","article-title":"Current levels of gonorrhoea screening in MSM in Belgium may have little effect on prevalence: a modelling study","volume":"146","author":"Buyze","year":"2018","journal-title":"Epidemiol Infect"},{"key":"2023042714160618900_ofad165-B22","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/OLQ.0000000000001189","article-title":"Population-level benefits of extragenital gonorrhea screening among men who have sex with men: an exploratory modeling analysis","volume":"47","author":"Earnest","year":"2020","journal-title":"Sex Transm Dis"},{"key":"2023042714160618900_ofad165-B23","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/oxfordjournals.aje.a008926","article-title":"Modeling prevention strategies for gonorrhea and chlamydia using stochastic network simulations","volume":"144","author":"Kretzschmar","year":"1996","journal-title":"Am J Epidemiol"},{"key":"2023042714160618900_ofad165-B24","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1098\/rstb.1999.0431","article-title":"The transmission dynamics of gonorrhoea: modelling the reported behaviour of infected patients from Newark, New Jersey","volume":"354","author":"Garnett","year":"1999","journal-title":"Philos Trans R Soc B Biol Sci"},{"key":"2023042714160618900_ofad165-B25","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/OLQ.0000000000000876","article-title":"Estimated impact of screening on gonorrhea epidemiology in the United States: insights from a mathematical model","volume":"45","author":"Tuite","year":"2018","journal-title":"Sex Transm Dis"},{"key":"2023042714160618900_ofad165-B26","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1093\/infdis\/jix450","article-title":"Impact of rapid susceptibility testing and antibiotic selection strategy on the emergence and spread of antibiotic resistance in gonorrhea","volume":"216","author":"Tuite","year":"2017","journal-title":"J Infect Dis"},{"key":"2023042714160618900_ofad165-B27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003077","article-title":"Adaptive guidelines for the treatment of gonorrhea to increase the effective life span of antibiotics among men who have sex with men in the United States: a mathematical modeling study","volume":"17","author":"Yaesoubi","year":"2020","journal-title":"PLoS Med"},{"key":"2023042714160618900_ofad165-B28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/sextrans-2014-051760","article-title":"Oral and anal sex are key to sustaining gonorrhoea at endemic levels in MSM populations: a mathematical model","volume":"91","author":"Hui","year":"2015","journal-title":"Sex Transm Infect"},{"key":"2023042714160618900_ofad165-B29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050522","article-title":"What drives the US and Peruvian HIV epidemics in men who have sex with men (MSM)?","volume":"7","author":"Goodreau","year":"2012","journal-title":"PLoS One"},{"key":"2023042714160618900_ofad165-B30","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/cid\/cix439","article-title":"Incidence of gonorrhea and chlamydia following human immunodeficiency virus preexposure prophylaxis among men who have sex with men: a modeling study","volume":"65","author":"Jenness","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2023042714160618900_ofad165-B31","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1093\/infdis\/jiw223","article-title":"Impact of the Centers for Disease Control's HIV preexposure prophylaxis guidelines for men who have sex with men in the United States","volume":"214","author":"Jenness","year":"2016","journal-title":"J Infect Dis"},{"key":"2023042714160618900_ofad165-B32","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1007\/s10461-021-03526-z","article-title":"Awareness of, willingness to take PrEP and its actual use among Belgian msm at high risk of HIV infection: secondary analysis of the Belgian European MSM internet survey","volume":"26","author":"Buffel","year":"2022","journal-title":"AIDS Behav"},{"key":"2023042714160618900_ofad165-B33","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1093\/pubmed\/fdz052","article-title":"Factors related to condomless anal intercourse between men who have sex with men: results from a European bio-behavioural survey","volume":"42","author":"Sherriff","year":"2020","journal-title":"J Public Health (Oxf)"},{"key":"2023042714160618900_ofad165-B34","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-033852","article-title":"Introducing pre-exposure prophylaxis to prevent HIV acquisition among men who have sex with men in Sweden: insights from a mathematical pair formation model","volume":"10","author":"Hansson","year":"2020","journal-title":"BMJ Open"},{"key":"2023042714160618900_ofad165-B35","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1473-3099(20)30778-7","article-title":"Antibacterial mouthwash to prevent sexually transmitted infections in men who have sex with men taking HIV pre-exposure prophylaxis (PReGo): a randomised, placebo-controlled, crossover trial","volume":"21","author":"Van Dijck","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2023042714160618900_ofad165-B36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/apc.2017.0027","article-title":"The duality of oral sex for men who have sex with men: an examination into the increase of sexually transmitted infections amid the age of HIV prevention","volume":"31","author":"Glynn","year":"2017","journal-title":"AIDS Patient Care STDS"},{"key":"2023042714160618900_ofad165-B37","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1080\/00918369.2019.1616430","article-title":"Factors associated with condom use among a sample of men who have sex with men (MSM) residing in rural Oklahoma","volume":"67","author":"Giano","year":"2020","journal-title":"J Homosex"},{"key":"2023042714160618900_ofad165-B38","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1037\/hea0000230","article-title":"Is anyone around me using condoms? Site-specific condom-use norms and their potential impact on condomless sex across various gay venues and websites in the Netherlands","volume":"34","author":"van den Boom","year":"2015","journal-title":"Heal Psychol"},{"key":"2023042714160618900_ofad165-B39","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0091-7435(02)00058-0","article-title":"Asymptomatic sexually transmitted diseases: the case for screening","volume":"36","author":"Farley","year":"2003","journal-title":"Prev Med"},{"key":"2023042714160618900_ofad165-B40","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1093\/jac\/dkaa300","article-title":"Treatment efficacy for pharyngeal Neisseria gonorrhoeae: a systematic review and meta-analysis of randomized controlled trials","volume":"75","author":"Kong","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"2023042714160618900_ofad165-B41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00007435-199501000-00007","article-title":"Treating uncomplicated Neisseria gonorrhoeae infections","volume":"22","author":"Moran","year":"1995","journal-title":"Sex Transm Dis"},{"key":"2023042714160618900_ofad165-B42","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.3390\/jcm8122182","article-title":"Efficacy and safety of injectable and oral antibiotics in treating gonorrhea: a systematic review and network meta-analysis","volume":"8","author":"Yang","year":"2019","journal-title":"J Clin Med"},{"key":"2023042714160618900_ofad165-B43","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/sti.59.3.176","article-title":"Comparison of ceftriaxone with cefoxitin in the treatment of penicillin-resistant gonococcal urethritis","volume":"59","author":"Zajdowicz","year":"1983","journal-title":"Sex Transm Infect"},{"key":"2023042714160618900_ofad165-B44","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00007435-199505000-00002","article-title":"Time required for elimination of neisseria gonorrhoeae from the urogenital tract in men with symptomatic urethritis","volume":"22","author":"Haizlip","year":"1995","journal-title":"Sex Transm Dis"},{"key":"2023042714160618900_ofad165-B45","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fmicb.2011.00052","article-title":"New concepts in immunity to Neisseria gonorrhoeae: innate responses and suppression of adaptive immunity favor the pathogen, not the host","volume":"2","author":"Liu","year":"2011","journal-title":"Front Microbiol"},{"key":"2023042714160618900_ofad165-B46","author":"De Baetselier","year":"2022"},{"key":"2023042714160618900_ofad165-B47","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1136\/sextrans-2011-050049","article-title":"Core groups, antimicrobial resistance and rebound in gonorrhoea in North America","volume":"88","author":"Chan","year":"2012","journal-title":"Sex Transm Infect"},{"key":"2023042714160618900_ofad165-B48","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/0956462420948739","article-title":"Background review for the 2020 European guideline for the diagnosis and treatment of gonorrhoea in adults","volume":"32","author":"Unemo","year":"2021","journal-title":"Int J STD AIDS"},{"key":"2023042714160618900_ofad165-B49","first-page":"505","article-title":"Clinical pharmacokinetics of azithromycin [in French]","volume":"43","author":"Singlas","year":"1995","journal-title":"Pathol Biol (Paris)"},{"key":"2023042714160618900_ofad165-B50","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1043661802002384","article-title":"Pharmacokinetics of azithromycin in lung tissue, bronchial washing, and plasma in patients given multiple oral doses of 500 and 1000 mg daily","volume":"46","author":"Di Paolo","year":"2002","journal-title":"Pharmacol Res"},{"key":"2023042714160618900_ofad165-B51","first-page":"17","article-title":"Pharmacokinetic profile of ceftriaxone in man","volume":"77","author":"Patel","year":"1984","journal-title":"Am J Med"},{"key":"2023042714160618900_ofad165-B52","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25407","article-title":"Daily and event-driven pre-exposure prophylaxis for men who have sex with men in Belgium: results of a prospective cohort measuring adherence, sexual behaviour and STI incidence","volume":"22","author":"Vuylsteke","year":"2019","journal-title":"J Int AIDS Soc"},{"key":"2023042714160618900_ofad165-B53","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3201\/eid2407.172104","article-title":"Effects of sexual network connectivity and antimicrobial drug use on antimicrobial resistance in Neisseria gonorrhoeae","volume":"24","author":"Kenyon","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"2023042714160618900_ofad165-B54","doi-asserted-by":"crossref","DOI":"10.1128\/aac.02294-21","article-title":"Markedly increasing antibiotic resistance and dual treatment of Neisseria gonorrhoeae isolates in Guangdong, China, from 2013 to 2020","volume":"66","author":"Lin","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"2023042714160618900_ofad165-B55","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3390\/antibiotics10050515","article-title":"Choosing new therapies for gonorrhoea: we need to consider the impact on the pan-Neisseria genome. a viewpoint","volume":"10","author":"Kenyon","year":"2021","journal-title":"Antibiotics"},{"key":"2023042714160618900_ofad165-B56","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1810840115","article-title":"Estimating the proportion of bystander selection for antibiotic resistance among potentially pathogenic bacterial flora","volume":"115","author":"Tedijanto","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023042714160618900_ofad165-B57","doi-asserted-by":"crossref","first-page":"e452","DOI":"10.1016\/S2666-5247(22)00044-1","article-title":"Europe-wide expansion and eradication of multidrug-resistant Neisseria gonorrhoeae lineages: a genomic surveillance study","volume":"3","author":"S\u00e1nchez-Bus\u00f3","year":"2022","journal-title":"Lancet Microbe"},{"key":"2023042714160618900_ofad165-B58","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/infdis\/jiab091","article-title":"The mosaic mtr locus as major genetic determinant of azithromycin resistance of Neisseria gonorrhoeae\u2014Germany, 2018","volume":"224","author":"Banhart","year":"2021","journal-title":"J Infect Dis"},{"key":"2023042714160618900_ofad165-B59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41598-021-03995-1","article-title":"Antimicrobial susceptibility of commensal Neisseria in a general population and men who have sex with men in Belgium","volume":"12","author":"Laumen","year":"2022","journal-title":"Sci Rep"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofad165\/49648821\/ofad165.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/10\/4\/ofad165\/50112969\/ofad165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/10\/4\/ofad165\/50112969\/ofad165.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T14:17:26Z","timestamp":1682605046000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofad165\/7086654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,27]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofad165","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,4,1]]},"published":{"date-parts":[[2023,3,27]]},"article-number":"ofad165"}}